Axon Enterprise (NASDAQ:AXON) Shares Down 7.4% on Analyst Downgrade

Axon Enterprise, Inc (NASDAQ:AXON)’s stock price traded down 7.4% during trading on Thursday after TD Cowen lowered their price target on the stock from $950.00 to $825.00. TD Cowen currently has a buy rating on the stock. Axon Enterprise traded as low as $362.30 and last traded at $362.4980. 350,025 shares were traded during trading, a decline of 65% from the average session volume of 997,971 shares. The stock had previously closed at $391.53.

Other equities research analysts have also issued reports about the stock. The Goldman Sachs Group dropped their price objective on shares of Axon Enterprise from $720.00 to $625.00 and set a “buy” rating on the stock in a report on Wednesday. Piper Sandler dropped their price objective on shares of Axon Enterprise from $753.00 to $690.00 and set an “overweight” rating on the stock in a report on Wednesday, February 25th. Northcoast Research upgraded shares of Axon Enterprise from a “neutral” rating to a “buy” rating and set a $742.00 price objective on the stock in a report on Tuesday, January 6th. Weiss Ratings restated a “hold (c-)” rating on shares of Axon Enterprise in a report on Friday, March 27th. Finally, Barclays dropped their price objective on shares of Axon Enterprise from $702.00 to $682.00 and set an “overweight” rating on the stock in a report on Wednesday, February 25th. Sixteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $755.88.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, insider Isaiah Fields sold 2,000 shares of Axon Enterprise stock in a transaction on Friday, February 27th. The shares were sold at an average price of $535.01, for a total value of $1,070,020.00. Following the sale, the insider directly owned 55,588 shares in the company, valued at approximately $29,740,135.88. The trade was a 3.47% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction on Wednesday, February 25th. The shares were sold at an average price of $500.24, for a total transaction of $5,002,400.00. Following the completion of the sale, the chief executive officer owned 3,090,997 shares in the company, valued at $1,546,240,339.28. The trade was a 0.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 13,855 shares of company stock worth $7,109,828. 4.40% of the stock is owned by insiders.

Axon Enterprise News Roundup

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Wall Street reaffirmations and bullish notes tied to Axon Week and new AI products have supported the stock recently; several analysts reiterated buy ratings and highlighted AI-driven growth as a reason to view the pullback as a buying opportunity. Why Axon Stock Bounced Back After Falling 10%
• Positive Sentiment: Axon unveiled new AI offerings (Axon Vision, expanded Axon Assistant, Axon 911) at its annual conference intended to boost real-time public-safety data capabilities — a product roadmap that analysts say could drive multi-year revenue and margin improvement. Can Axon’s New AI Suite Reframe Its Real-Time Data Advantage Story for Investors (AXON)?
• Neutral Sentiment: Analysts trimmed price targets (Goldman Sachs and TD Cowen cut targets) but largely maintained constructive ratings — this reduces upside in the near term while leaving longer-term bull cases intact. Goldman Sachs price target update
• Neutral Sentiment: Sector/market news (e.g., coverage of peers and ad-tech moves) may be pulling investor attention and flows away from defensible growth stories, but these items are indirect for Axon. Macquarie sees AppLovin’s e-commerce push as a multi-year growth driver
• Negative Sentiment: New legal risk headlines tied to the company’s HQ and the cumulative effect of price-target cuts triggered fresh selling pressure; those headlines were cited by market coverage as a primary reason shares moved lower. Why Axon (AXON) Shares Are Trading Lower Today
• Negative Sentiment: Today’s decline was compounded by momentum selling and elevated volume after yesterday’s drop; market commentary and drop reports amplified the move. Axon Enterprise (AXON) Stock Drops Despite Market Gains

Institutional Investors Weigh In On Axon Enterprise

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Rockefeller Capital Management L.P. increased its stake in Axon Enterprise by 53.2% in the 4th quarter. Rockefeller Capital Management L.P. now owns 11,518 shares of the biotechnology company’s stock valued at $6,542,000 after buying an additional 4,002 shares during the last quarter. World Investment Advisors increased its holdings in Axon Enterprise by 37.1% during the fourth quarter. World Investment Advisors now owns 1,035 shares of the biotechnology company’s stock worth $588,000 after buying an additional 280 shares during the last quarter. Pure Financial Advisors LLC raised its position in Axon Enterprise by 6.7% during the fourth quarter. Pure Financial Advisors LLC now owns 364 shares of the biotechnology company’s stock worth $207,000 after acquiring an additional 23 shares in the last quarter. Tobam raised its position in Axon Enterprise by 17.3% during the fourth quarter. Tobam now owns 5,833 shares of the biotechnology company’s stock worth $3,313,000 after acquiring an additional 859 shares in the last quarter. Finally, Clearwave Capital LLC acquired a new stake in Axon Enterprise in the fourth quarter valued at $325,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Trading Down 10.3%

The business’s 50 day simple moving average is $467.16 and its 200 day simple moving average is $569.82. The stock has a market cap of $28.25 billion, a price-to-earnings ratio of 231.14, a PEG ratio of 8.36 and a beta of 1.61. The company has a quick ratio of 2.29, a current ratio of 2.53 and a debt-to-equity ratio of 0.53.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Tuesday, February 24th. The biotechnology company reported $2.15 EPS for the quarter, beating analysts’ consensus estimates of $1.60 by $0.55. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.82%. The company had revenue of $796.72 million during the quarter, compared to the consensus estimate of $755.29 million. During the same quarter last year, the firm posted $2.08 EPS. The company’s quarterly revenue was up 38.5% on a year-over-year basis. On average, research analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.